Skip to main content
. Author manuscript; available in PMC: 2021 Oct 21.
Published in final edited form as: Biomater Sci. 2020 Sep 2;8(20):5516–5537. doi: 10.1039/d0bm01183e

Figure 1.

Figure 1.

Left: Non-immunogenic “cold” tumor characterized by M2 macrophage polarization, upregulation of vascular endothelial growth factor (VEGF), regulatory T cell (Tregs), downregulation of tumor antigen cross-presentation and tumor infiltrating lymphocyte (TIL) count. Right: Immunogenic “Hot” tumor characterized by M1 macrophage polarization, upregulation of tumor antigen presentation and TIL count, and downregulation of VEGF, Tregs and other immunosuppressive factors.